Lehrer 2008.
Trial name or title | NCT‐ 00712270 |
Methods | Allocation: random. Blindness: double blind. Duration: 16 weeks. Design: parallel. |
Participants | Diagnosis: schizophrenia. Age 18‐55 years. Gender: male and female participants. History: duration of illness not reported. Setting: not specified. |
Interventions | 1. Aripiprazole. 2. Risperidone. |
Outcomes | Predict differential antipsychotic drug treatment response using PET and MRI. |
Starting date | April 2005 |
Contact information | Kettring Health Network |
Notes |